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Abstract
Hypothermia is a key symptom of sepsis, but the mechanism(s) leading to hypothermia during 
sepsis is largely unknown and thus no effective therapy is available for hypothermia. Therefore, it 
is important to investigate the mechanisms and develop effective therapeutic methods. 
Lipopolysaccharide (LPS)-induced hypothermia accompanied by excess nitric oxide (NO) 
production, lead to a reduction in energy production in wild type mice. However, mice lacking 
inducible nitric oxide synthase did not suffer from LPS-induced hypothermia, suggesting that 
hypothermia is associated with excess NO production during sepsis. This observation is supported 
by the treatment of wild type mice with α-lipoic acid (LA) in that it effectively attenuates LPS-
induced hypothermia with decreased NO production. We also found that LA partially restored 
ATP production, and activities of the mitochondrial enzymes involved in energy metabolism, 
which were inhibited during sepsis. These data suggest that hypothermia is related to 
mitochondrial dysfunction, which is likely compromised by excess NO production and that LA 
administration attenuates hypothermia mainly by protecting mitochondrial enzymes from NO 
damage.
Keywords
Lipoic acid; antioxidant; mitochondria; body energy
Correspondence to: Dr. Xianwen Yi, Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, 
710 Brinkhous-Bullitt Building, Chapel Hill, NC 27599-7525, Phone: +1 919-966-6916, Fax: + 1 919-966-8800, 
xyi2000@med.unc.edu. 
Author Disclosure Statement
The authors declare that no competing financial interests exist.
HHS Public Access
Author manuscript
Free Radic Biol Med. Author manuscript; available in PMC 2017 February 07.
Published in final edited form as:














Sepsis remains a critical problem resulting in high morbidity and mortality rates. In the 
United States alone, there are 751,000 estimated cases of sepsis every year with an overall 
mortality of 100,000 people [1]. The incidence of sepsis is expected to rise at a rate of 1.5% 
per year with total costs of $16.7 billion [2].
Both hyperthermia (body temperature >38 °C) and hypothermia (body temperature <36 °C) 
are key diagnostic criteria for sepsis [3]. Hypothermia results in an increased rate of wound 
infection, coagulopathy and other postoperative complications [4], and is particularly 
associated with severe infection and a higher mortality rate [5, 6]. The mechanism for 
hypothermia remains largely unknown. Many strategies have been proposed for the 
treatment of sepsis, but few noteworthy breakthroughs have been made during the past 
several decades [7]. Since there is no effective therapy to prevent hypothermia, it is also 
clinically important to develop effective methods for modulating hypothermia.
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are involved in sepsis 
[8-10]. One of the characteristic features of sepsis is markedly increased levels of plasma 
nitric oxide (NO) [11]. NO plays an important role in oxidative phosphorylation [12], and it 
is well-known that excess NO causes inhibition of complexes I and IV in the electron 
transport chain in several ways [13-15]. Antioxidant therapy is a plausible adjunctive method 
for treatment of sepsis. Among antioxidants, α-lipoic acid (1, 2-dithiolane-3-pentanoic acid; 
LA) is a well-known potent antioxidant with anti-inflammatory activity [16-18]. LA is also a 
cofactor for several enzymes including pyruvate dehydrogenase complex (PDH; EC1.2.4.1 + 
EC 1.6.4.3 + EC 2.3.1.2) and α-ketoglutarate dehydrogenase complex (KDH; EC 1.2.4.2 + 
EC 2.3.1.61 + EC 1.8.1.4), two enzymes located in mitochondria and involved in energy 
production. LA has a therapeutic potential in mitochondria-related disorders [19, 20]. We 
have previously reported that a mouse embryo cannot survive without endogenous LA 
production, strongly suggesting that LA is essential for maintenance of normal levels of 
energy metabolism in addition to its antioxidant activity [21].
Lipopolysaccharide (LPS) administration may produce hypothermia in rodents [22, 23]. In 
the current study, we hypothesize that excess production of NO during sepsis inhibits some 
proteins in the Krebs cycle and the mitochondrial respiratory chain, leading to overall energy 
deficiency. To demonstrate this, we treated mice with LPS to induce hypothermia and 
studied molecular and physiological responses associated with this treatment. In this study, 
we found that LA increased mitochondrial antioxidant capacity, partially restored enzymatic 
activities in two mitochondrial enzymes, and ATP yield. These changes may contribute to 
the modification of hypothermia-associated sepsis mechanisms.
Materials and Methods
Materials
R-(+)-α-lipoic acid was from Toronto Chemical Research (Toronto, Canada), and 
Cytochrome C from Sigma Aldrich (St. Louis, MO).
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LPS-induced endotoxic shock in mice
Three-month-old female C57BL/6J mice, and female iNOS-null mice were given 
intraperitoneally (i.p.) a dose (4 mg/kg body weight) of LPS (E. Coli 055:B5, Sigma, St. 
Louis), or saline as a control [18, 24]. Half of each of the LPS-treated and control mice 
received i.p. a single injection (40 mg/kg body weight) of LA 30 min before or after the LPS 
injection [18]. To help distinguish the effect of LA on hypothermia from other antioxidants, 
four LPS-treated mice were i.p. injected with ascorbate (pH 7.0 previously adjusted with 
NaOH; 5 mg/g of body weight) [25]. The dosage of LA was based on our experience and 
that of other investigators [26-29]. Body temperature was monitored for 4 hours after LPS 
injection using rectal temperature sensors (Physitemp Instruments Inc. Clifton, NJ). The 
experimental protocols were approved by the Institutional Animal Care and Use Committee 
of the University of North Carolina and complied with the U. S. National Institutes of Health 
standards.
Nitrate/Nitrite (NOx) Assay
Plasma nitrate (NO3−) and nitrite (NO2−) levels, indicators of the production of NO, were 
measured after 4 hours of LPS injection using a colorimetric assay kit (Cayman Chemical, 
Ann Arbor, MI). The absorbance was read on a Biotek Synergy HT Multi-Mode Microplate 
Reader (Winooski, VT) using a wavelength of 540 nm.
Mitochondria isolation
Liver mitochondria were isolated following protocols already published [30, 31] with minor 
modifications. Mice were sacrificed by cervical dislocation and the liver was rapidly 
explanted from the peritoneal cavity. The liver was immersed in ice-cold isolation buffer 
[100 mM Tris– 3-(N-morpholino) propanesulfonic acid (MOPS, Sigma Aldrich), 10 mM of 
ethylene-bis (oxyethylenenitrilo) tetraacetic acid tetrasodium (EGTA, Sigma Aldrich)/Tris 
and 200 mM sucrose, pH 7.4] and chopped finely with scissors and then rinsed with the 
isolation buffer several times to remove traces of blood. Chopped tissue was homogenized in 
the buffer, with 12 strokes of a loose pestle in a glass Dounce. The homogenate was 
centrifuged for 10 min at 3,000 g at 4° C. Supernatants (including the pink salmon layer 
above the pellet) were collected in isolation buffer and then centrifuged for 10 min at 10,000 
g at 4° C. The resulting pellets were finally re-suspended in ~1 ml isolation buffer and 
retained on ice until use (within 4 hours).
Determination of reduced glutathione (GSH) levels in mitochondria
Liver mitochondrial levels of reduced GSH were determined using a commercially kit 
(Cayman Chemical) following the manufacturer's instructions. The protein concentration of 
each sample was determined using a bicinchoninic acid assay (BCA; Thermo Scientific, 
Rockford, IL).
Determination of ATP production levels
ATP generation in LPS-treated liver homogenate was analyzed by a luciferase substrate 
assay (Invitrogen, Carlsbad, CA). Briefly, LPS-treated mice, in the presence or absence of 
LA, were sacrificed 4 hours after the LPS injection. The liver was homogenized, and the 
Hiller et al. Page 3













homogenate was sonicated in ATP Assay Buffer provided by the company. After 
centrifugation at 12,000 g for 5 minutes at 4° C, the supernatant was removed and used for 
ATP measurement in an Orion Microplate Luminometer (Berthold Detection Systems, 
Titertek Instruments, Inc., Huntsville, AL). For calculations the amount of ATP was 
normalized by protein concentration as determined using the BCA method.
Alpha-ketoglutarate dehydrogenase and complex III activities
KDH activity was determined by monitoring NAD+ reduction at 340 nm. Isolated liver 
mitochondria were suspended in medium containing 25 mM KH2PO4, 5 mM MgCl2, 0.5 
mM EDTA, 0.1% (v/v) Triton X-100, 40 mM rotenone, 1.0 mM NAD+, 0.2 mM thiamin 
pyrophosphate, and 0.1 mM Coenzyme A, pH 7. The mitochondria were sonicated in a 
water bath (Denville Scientific, South Plainfield, NJ) at room temperature for 1 min. A 
reaction mixture containing 5 mM MgCl2, 40 mM rotenone, 0.1 mM Coenzyme A, 0.2 mM 
thymine pyrophosphate, and 1 mM NAD+ were added to the mitochondrial medium to reach 
a final concentration of 0.4 mg mitochondrial protein/ml. The reaction was initiated by 
adding 2.5 mM α-ketoglutarate [32-34].
Complex III (ubiquinol-ferricytochrome C oxidoreductase; EC 1.10.2.2) activity was 
measured by following an increase in absorbance at 550 nm due to the reduction of 
ferricytochrome C [35, 36]. The reaction mixture consisted of 25 mM KH2PO4, pH 7.4, 5 
mM MgCl2, 2 mM KCN, 2.5 mg bovine serum albumin, 50 μM cytochrome C, and 4 mg 
rotenone. Mitochondrial protein (25 μg) was added and the reaction was initiated by the 
addition of 60 μM decylubiquinol; any increase in absorbance at 550 nm was monitored for 
2 minutes. The assay was repeated, but with the inclusion of 5 μg antimycin A to the 
reaction mixture to determine antimycin A-insensitive activity. Antimycin A-sensitive 
complex III activity was determined using the initial rate as baseline. Enzyme activity was 
expressed as nmole of reduced cytochrome C/minute per mg of protein.
PGE2 and cytokine analyses
The levels of prostaglandins E2 (PGE2) and cortisone were measured by an enzyme 
immunoassay kit (Cayman Chemical), according to the manufacturer's instructions. Plasma 
levels of interleukin-6 (IL-6) and tumor necrosis factor (TNF-α) in plasma were measured 
using a LINCO multiplex mouse cytokine kit (Linco Research, Inc., St. Charles, MO) on a 
Luminex 100 system, according to the manufactures’ protocols (Luminex Corporation, 
Austin, TX).
Statistical analysis
All data are reported as means ± S.E.M. Values of p<0.05 were considered to be statistically 
significant (95% confidence limits). The effects of NO and LA were analyzed using 
ANOVA. Effects of fluctuation in body temperature were assessed by MANOVA by 
repeated measurements of each mouse's physiological conditions.
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α-Lipoic acid attenuates LPS-induced hypothermia mediated by decreasing excessive NO 
production during sepsis
Injection of LPS in C57BL/6 wild type (WT) mice induced a drop in body temperature from 
an initial 36.5 °C to a mean nadir of 28 °C during the 4 hours following LPS treatment (ΔT 
= − 8.5 °C) (Figure 1A). In contrast, a temperature drop in C57BL/6 mice lacking the 
inducible nitric oxide synthase (iNOS) was considerably attenuated (Figure 1A; ΔT = 
− 3.0 °C). Administering LA (40 mg/kg body weight) to WT mice 30 min prior to LPS 
injection protected them from hypothermia to a similar degree as untreated WT mice, but 
gave no further protection to the LPS-treated iNOS null mice (Figure 1). During the four 
hours of observation, the body temperature of the WT mice that were not treated with LPS 
remained unchanged (ΔT < 0.5 °C) and LA supplementation alone did not affect body 
temperature (data not shown). Supplementing with LA at 30 min post LPS injection was 
equally effective in preventing hypothermia as illustrated in Figure 1B. In addition, there 
was no significant attenuation of hypothermia in septic mice treated with ascorbate (Figure 
1B).
Next, we measured changes in total plasma nitrate/nitrite (NOx) after LPS injection since 
the circulating levels of NOx represent overall NOS activity. At 4 hours post-injection, NOx 
levels were increased 11-fold in WT mice (Figure 2). LA markedly attenuated LPS-induced 
NOx increase in WT mice but not in iNOS null mice (Figure 2). LPS injection decreased 
eNOS (endothelial nitric oxide synthase) gene expression by 5% and increased iNOS gene 
expression by 1700% in WT mouse liver. On the other hand, administration of LA did not 
significantly change the expression of eNOS and iNOS at 4 hours after LPS injection (P = 
0.15 and 0.43, respectively; data not shown). Taken together, these data suggest that iNOS-
derived NO is a major source of the NOx responsible for hypothermia during sepsis, and that 
the thermoregulatory effect of LA is mediated through NO.
Effect of LA on ATP production, mitochondrial functions and redox status
To investigate whether partial restoration of the body temperature is due to sustained energy 
metabolism, we measured ATP production in the liver. At 4 hours post LPS injection, liver 
ATP content in WT mice was reduced by 40% compared with un-treated mice, but addition 
of LA completely blocked this reduction (Figure 3A). ATP level in LPS-treated iNOS−/− 
mice did not significantly drop compared with non-treated control, and LA supplementation 
did not increase ATP production (Figure 3B).
To evaluate whether administration of LA may compensate for possible loss of 
mitochondrial antioxidant capacity, we measured GSH levels in mitochondria. We observed 
that the liver mitochondrial GSH content was decreased by about 40% after LPS treatment 
(P<0.01) and LA-treated mice almost fully retained their original GSH levels (Figure 3C).
Complex III and KDH activities
Enzymatic assay of complex III in the mitochondria isolated from WT mouse liver 
demonstrates a 40% decrease in its activity at 4 hours post-injection of LPS, which is 
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attenuated in the presence of LA (P<0.05) (Figure 4A). Likewise, KDH activity dropped by 
about 50% while LA partially prevented this reduction (P<0.01) (Figure 4C). We also found 
that KDH activity in liver mitochondria was not significantly altered in septic mice treated 
with ascorbate (Figure 4C). These results suggest that ascorbate supplementation does not 
completely share the same mechanisms as LA in terms of hypothermia treatment. In 
addition, both complex III and KDH activity in the mitochondria isolated from iNOS−/− 
mouse liver did not significantly decrease after injection of LPS and addition of LA did not 
show any obvious effect for the enzyme activities (Figures 4B and 4D).
Examination of other possible regulatory factors for hypothermia
To explore other possible thermoregulatory mechanisms involving LA in addition to NO, we 
examined the effect of LA on PGE2 and cytokines. Our results showed that PGE2 levels in 
serum in all non-LPS treated mice were very low (with LA: 90 ± 12 pg/ml; without LA 85 
± 12 pg/ml). Serum PGE2 levels were increased at 2 hours (687 ± 72 pg/ml), continued to 
rise at 4 hours (1,115 ± 55 pg/ml) and reached a plateau at 24 hours post LPS challenge 
(Figure 5A). Treatment with LA did not significantly change serum PGE2 levels (At 2 hour: 
654 ± 114 pg/ml; at 4 hours: 1,156 ± 65 pg/ml) (Figure 5A). Similarly, concentrations of 
serum TNF-α (Figure 5B) and IL-6 (Figure 5C) were markedly increased at 2 hours (TNF-
α: 7.5 ± 0.98 ng/ml; IL-6: 25.4 ± 2.1 ng/ml) and 4 hours (TNF-α: 4.5 ± 0.32 ng/ml; IL-6: 
20.4 ± 1.26 ng/ml) following LPS injection; but LA supplementation did not significantly 
affect their levels (TNF-α: 5.6 ± 1.1 ng/mg; IL-6: 26.2 ± 1.8 ng/ml at 2 hours; TNF-α: 3.9 
± 1.42 ng/ml; IL-6: 22.4 ± 2.1) at 4 hours; i.e. thermoregulation via LA neither directly 
affects levels of PGE2 nor pro-inflammatory cytokines.
Discussion
In this study, we found that treatment with LA significantly attenuates LPS-induced 
hypothermia in septic mice. Thermoregulation by LA is likely associated with its ability to 
protect mitochondria by markedly decreasing NO production and increasing mitochondrial 
antioxidant capacity. Our data shows that LA treatment significantly decreased LPS-induced 
accumulation of the major nitric oxide end products (NO3− and NO2−) without significantly 
affecting eNOS and iNOS gene expression, suggesting that decrease of NO by LA is 
primarily through inhibiting NO biosynthesis. Excessive NO produced during sepsis is 
expected to be involved in impairment of mitochondrial enzymes. It is well-known that 
excessive NO interacts with the mitochondrial respiratory chain by inhibiting cytochrome c 
oxidase (complex IV) and NADH-ubiquinone oxidoreductase (complex I) [37-39]. We find 
that activities of two other enzymes, KDH and complex III, are also decreased by excessive 
NO in LPS-treated WT mice and the activities are partially restored by LA supplementation. 
Our study presents new RNS targets and extends the knowledge about the protective 
capabilities of LA. KDH is in a key regulatory step of the Krebs cycle [40], which 
determines the capacity of mitochondrial metabolism [41], and could play a vital role in the 
ROS-associated bioenergetic deficit [42]. Complex III is a central component of all primary 
energy transduction systems. It functions in maintaining the proton gradient, which provides 
about 30% of energy production [43]. Therefore, it is possible that the decrease in catalytic 
activities of the two enzymes contributes to decreased ATP production, leading to 
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hypothermia during sepsis, since mitochondria generate more than 90-95% of ATP in the 
body [44]. This assumption is supported by the observation in iNOS−/− mice in which body 
temperature does not significantly drop upon injection of LPS. In addition, ATP production, 
enzymatic activities of KDH and complex III in iNOS−/− mice neither significantly decrease 
after LPS injection, nor respond to LA supplementation. These data strongly suggest that 
excessive NO induced by LPS injection plays a critical role in hypothermia formation and a 
link may exist between NO levels and amount of ATP synthesis. On the other hand, since 
GSH is predominantly an intra-mitochondrial antioxidant [12] that protects mitochondrial 
complexes from NO-induced damage [45], a declined GSH level weakens mitochondrial 
antioxidant defense and deteriorates mitochondrial function. It has been observed that GSH 
decreases when NO production increases [38]. Our result showed that the decreased 
mitochondrial GSH levels were partially restored with LA treatment. Since both GSH and 
LA are thiol antioxidants, treatment with LA may spare consumption of GSH [46], and 
reduce formation of protein disulfide bridges [47]. In addition, LA can raise GSH levels by 
reducing cystine to cysteine, a GSH precursor [48]. However, it is not certain whether this 
reaction can take place under the oxidative stress conditions. The increased mitochondrial 
GSH levels by LA may provide protection from NO-induced damage to mitochondrial 
components related to energy production like KDH, and consequently attenuate 
hypothermia. It is known that KDH is sensitive to ROS/RNS such as hydrogen peroxide, 
peroxynitrite and nitric oxide [49, 50]. Thus, it is not surprising at the outcome that enzyme 
activity decreases during sepsis.
These data are also consistent with previous observations from our and other investigators. 
For instance, human endothelial cells exposed to serum from patients with sepsis have 
shown lower rates of mitochondrial respiration and significantly reduced ATP production 
than cells treated with serum from healthy volunteers [51, 52]. Likewise, in vitro studies 
showed mitochondrial complex inhibition by RNS with decreased ATP synthesis [52, 53]. 
Additionally, mitochondrial damage develops into energetic failure during sepsis, leading to 
cell death and organ failure [54, 55]. Moreover, sepsis-associated oxidative stress can be 
effectively quenched by LA treatment [18, 56]. Our previous data showed that LA in 
hepatocytes decreased noticeably in LPS treated mice [18]. At this point it is not clear 
whether decreasing LA levels affect the availability of the cofactor for normal KDH 
function. The fact that KDH activity does not change with LA supplementation in LPS-
treated iNOS−/− mice indicates that KDH activity under these conditions is not dependent on 
the cofactor. Earlier reports have shown that LA administration improved the activities of 
KDH by improving the co-factor availability [57, 58]; however, these observations were 
made in aged animals, and they cannot be applied to studies in animals as young as those 
used in our studies.
Evidence shows that LA and ascorbate are powerful antioxidants that catalyze 
denitrosylation [59, 60]. However, ascorbate fails to prevent hypothermia. Thermoregulatory 
properties of LA may be related to its unique structure and physical/chemical characteristics. 
We believe that the presence of a thiol group in LA could result in better protection of 
mitochondria [61].
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Since hypothermia may be a reversible process, we extended the time of observation for 
body temperature from 4 hours to 24 hours to probe possible thermo-regulative mechanisms 
of LA. We found that low body temperature persisted for 24 hours post LPS injection and 
that the highest level of plasma NO occurred at 24 hours in septic mice. The 
thermoregulatory effect of LA weakened over time and body temperature increased <1°C 
6-8 hours after LPS injection, suggesting that extended exposure to NO could lead to 
irreversible inhibition of mitochondrial function, which is difficult to attenuate with a one-
time treatment of LA. Repeated treatment or a higher dose may be required to overcome this 
situation.
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• α-lipoic acid (LA) significantly attenuates hypothermia.
• LA restores enzymatic activities inhibited by excessive nitric oxide.
• Our results should provide a new strategy for effective treatment of sepsis.
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Time course of hypothermia in wild type (WT) and iNOS−/− mice induced by 
lipopolysaccharides (LPS). A). α-lipoic acid (LA) was given at 30 min prior to LPS 
injection. Animal number: WT+LA=17; WT-LA=14; iNOS−/−+LA=10; iNOS−/−-LA=10. 
B). LA or ascorbate were administered at 30 min after LPS injection. Data are expressed as 
means ± SEM. Animal number: WT+LA=12; WT-LA=13; iNOS−/−+LA=10; iNOS−/−-
LA=10; and WT+ascrobate=4.
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Total plasma nitrate/nitrite (NOx) immediately before, and 4 hours after LPS injection in 
septic mice. Values are the mean ± SEM. Statistical analysis are by one-way ANOVA.
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Effects of LA on energy production during sepsis. ATP content in the livers of the WT (A) 
and iNOS−/− mice (B) at 4 hours following LPS treatment. Control mice were injected with 
PBS. (C) Glutathione (GSH) levels in mitochondria isolated from liver of LPS-treated mice. 
All results are expressed as mean ± SEM. The numbers inside the bars indicate the number 
of animals used for each measurement.
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Activities of complex III and alpha-ketoglutarate dehydrogenase (KDH) in mitochondria 
isolated from liver of LPS-treated WT mice (A and C) and iNOS−/− mice (B and D) in the 
presence or absence of LA or ascorbate. (A and B) Complex III activity was expressed as 
nmole of reduced cytochrome C/minute per mg of protein. (C and D) KDH activity was 
determined by monitoring NAD+ reduction at 340 nm. The activities of two enzymes shown 
are the means ± SEM.
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Serum concentrations of (A) prostaglandin E2 (PGE2), (B) tumor necrosis factor alpha 
(TNF-α), and (C) interleukin-6 (IL-6) at 2 hours and 4 hours after intraperitoneal injection 
of LPS in mice supplemented with LA compared to controls. Error bars represent SEM.
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